pharmaphorum

DECEMBER 28, 2022

In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009. So, how do smaller pharmaceutical companies at the cutting edge get ready for their acquisition milestone, so they maximise their value and attractiveness?

Documentation 116

Documentation Pharmaceutical Companies Pharmaceutical Companies FDA 116

Impact Pharmaceutical Services

AUGUST 21, 2022

In 2009, IMPACT (now part of Syner-G BioPharma Group) was contracted by a mid-size global pharmaceutical company to prepare 2 Phase 3 clinical study reports (CSRs) for a biologic agent for the treatment of Crohn’s disease. Download a PDF of this case study. Establishment of a Long-Term Medical Writing Partnership.

Documentation 40

Documentation Pharmaceutical Companies Pharmaceutical Companies 40

pharmaphorum

NOVEMBER 26, 2020

Since the start of the year, pharmaceutical companies have been riding a rollercoaster of challenges. Dr Paul Tunnah founded pharmaphorum in 2009, which combines industry leading publications ( www.pharmaphorum.com ) with a specialist strategy and content marketing/communications consultancy ( www.pharmaphorumconnect.com ).

Communication 109

Communication Pharmaceutical Companies Pharmaceutical Companies 109

PharmaShots

MARCH 29, 2023

Shots: Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years. No generic version of Entresto has been approved in the US.

FDA 49

FDA Chemotherapy Immunization Dosage 49

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Vaccines 113

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 113

pharmaphorum

JULY 14, 2021

He was referring to his business’ share of misconduct related fines that, between 2009 and 2017, topped $342 billion across the US and Europe. It’s killing us.” As the sector looks to maintain its momentum, it must be wary that positive messaging and increased scrutiny does not end up as a recipe for a hard fall.

Pharmaceutical Companies 104

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 104

PharmaShots

FEBRUARY 21, 2023

The company expects to commence P-I clinical trials on metastatic and pediatric primary bone cancer patients. Other radiotherapies under the company's pipeline include Humalutin and Alpha37. The company is evaluating Iomab-B in a P-III clinical trial (SIERRA) in patients with relapsed or refractory acute myeloid leukemia (AML).

FDA 56

FDA Dosage Pharmaceutical Companies Pharmaceutical Companies 56

pharmaphorum

DECEMBER 2, 2020

Like most pharma companies of its size, Pfizer has faced its fair share of controversy as one of the most well-known drugmakers in the world. Since the turn of the millennium, Pfizer has embarked on a series of mega-mergers, gobbling up Warner-Lambert in 2000, Pharmacia and Upjohn in 2002, Wyeth in 2009, and Medivation in 2016.

Compounding 127

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 127

The People's Pharmacy

MAY 8, 2023

Since the start of 2013, pharmaceutical companies based in the U.S. The FDA apparently gave the company a green light to keep manufacturing and allowed ongoing generic drug export to the U.S. The Chinese company, Zhejiang HuaHai Pharmaceutical company in Linhai, China, had changed its manufacturing process.

FDA 72

FDA Pharmaceutical Companies Pharmaceutical Companies Medical Schools 72

European Pharmaceutical Review

AUGUST 24, 2023

This heightened focus from regulators is shifting the type of deals pharmaceutical companies are willing to execute, Baral noted. These mega deals created behemoth companies that needed to spread capital too thin and included redundancies due to unrealised synergies.

Pharmaceutical Companies 82

Pharmaceutical Companies Pharmaceutical Companies 82

Pharmaceutical Technology

AUGUST 26, 2008

It was once derided as the stuff of science fiction, but in recent years, biotechnology has emerged as an important growth area in pharmaceuticals. As understanding of biological systems has forged ahead, pharmaceutical companies have made increasing use of biotechnology in discovering and manufacturing new medicines.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Immunization 52

Pharmaceutical Technology

OCTOBER 5, 2008

“The business integration from 2005 to 2007 of the two separate companies to form the joint Daiichi Sankyo created one of Japan’s biggest pharmaceutical companies.” ” “The use of generic drugs is low in Japan, but health costs are increasing and the government has to do something to reduce costs.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling 52

pharmaphorum

JANUARY 5, 2021

For pharmaceutical companies there are a number of implications. For pharmaceutical companies, this may mean a change in patient journeys to pharmacotherapy becoming longer and more complex, but also occurring in different settings. It will take a decade to fully evaluate the true impact.

Hospitals 104

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 104

Pharma Marketing Network

JUNE 11, 2020

So, this was back in 2009, and I hosted a Halloween party at my house, and I decided to dress up as Hunter S. You know, in November 2009, the FDA held a public hearing about the promotion of Food and Drug Administrative Related Regulated Medical Products, using the internet and social media tools. So, I didn’t look so bad.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication FDA 52

pharmaphorum

FEBRUARY 16, 2021

Slaoui rose through the ranks at the big UK pharma and was appointed head of the company’s vaccines division in 2009, leaving in 2017 when Emma Walmsley took over as CEO at GSK.

Vaccines 57

Vaccines Pharmaceutical Companies Pharmaceutical Companies 57

PharmaShots

FEBRUARY 20, 2023

After the outbreak of any epidemic or pandemic, all the responsibilities come on the shoulders of pharmaceutical companies. With unprecedented diseases lurking on the corner, pharmaceutical companies, are now obligated to widen their conventional horizons and look for substitute practices in their drug development strategies.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Compounding 40

PharmaShots

APRIL 13, 2023

model is a holistic approach to incorporate the same strategy to life science and pharmaceutical companies. A globally fast-growing, and largest pharmaceutical company in the world was created through a merger between Pfizer and Pharmacia. Model: Inspired by the industry 4.0 model, the pharma 4.0

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Labelling 40

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines FDA Pharmaceutical Companies Pharmaceutical Companies 64

pharmaphorum

MARCH 30, 2021

Camilla has a well-recognised track record working with various multinational companies, including AstraZeneca, Novartis and Allergan. About the author.

Hospitals 109

Hospitals Communication Pharmaceutical Companies Pharmaceutical Companies 109

The People's Pharmacy

MARCH 20, 2023

Finally, there is the actual process by which pharmaceutical companies collect drug side effect information. How Do Drug Companies Ask Questions? It was published in Drug Safety in 2009. There is another very serious flaw in the way pharmaceutical companies collect drug side effect information.

Adverse Reactions 76

Adverse Reactions FDA Labelling Mayo Clinic 76

PharmaShots

JUNE 7, 2023

To further expedite the introduction of the biosimilar globally, EirGenix has been in talks with global pharmaceutical companies about licensing the marketing rights to EG1206A 5. The P-III trial of EG1206A is expected to be initiated shortly, estimated that the evaluation of the primary EPs will be completed within 2yrs.

FDA 40

FDA Packaging Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

MAY 11, 2008

Pharmaceutical companies, regulatory agencies and governments are becoming increasingly concerned about fraud and counterfeiting throughout the pharmaceutical supply chain, especially with the cost of drugs going up.

Packaging 52

Packaging Labelling Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

JULY 6, 2023

www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practice-cgmp-regulations 5 US Food and Drug Administration. ICH Q10 Pharmaceutical Quality System.” April 2009. By nature of their business, pharmaceutical companies are more risk-centric than other sectors, such as banking. March 2023.

Insurance 52

Insurance Documentation Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

JULY 6, 2023

9 As such, major investment is warranted for pharmaceutical companies to fully capitalize on the benefits of CM, and they need to make the hard business choice of investing time and money—with added risk—to widen their manufacturing portfolio versus putting money in established technologies that have been profitable.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Dosage Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

MARCH 7, 2023

A pharmaceutical quality system (PQS) is a management system used to direct and control a pharmaceutical company with regard to quality. link] 11 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline Q8 (R2): Pharmaceutical Development.”

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

Pharmaceutical Technology

MARCH 22, 2023

Large-molecule drugs such as biologics are particularly sensitive to foreign contamination and E&L interaction, making these issues key concerns for pharmaceutical companies. In addition, packaging components are not entirely manufactured in a clean room environment, making them a potential source of exogenous contamination.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52